|
⚲
|
| Mark Blumenkranz | |
|---|---|
| Firm | |
| Address | 1167 Massachusetts Avenue Arlington, Ma 02476 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Kala Bio Inc | 021-517395 | Director | 12.5 M of 12.5 M |
||
| Kala Pharmaceuticals Inc | 021-422740 | Director | 16.1 M of 36.5 M |
||
| Avalanche Biotechnologies Inc | 021-224222 | Director | 10.0 M of 10.0 M |
||
| Avalanche Biotechnologies Inc | 021-216374 | Director | 55.1 M of 56.0 M |
||
| Avalanche Biotechnologies Inc | 021-207011 | Director | 5.7 M of 6.1 M |
||
| Optimedica Corp | 021-187468 | Director | 35.0 M of 35.0 M |
||
| Oculeve Inc | 021-186287 | Director | 7.6 M of 7.6 M |
||
| Optimedica Corp | 021-77391 | Director | 30.2 M of 35.0 M |
||